BAVENCIO

This brand name is authorized in Austria, Australia, Brazil, Canada, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Japan, Lithuania, Netherlands, Poland, Romania, Singapore, Turkey, United Kingdom, United States

Active ingredients

The drug BAVENCIO contains one active pharmaceutical ingredient (API):

1 Avelumab UNII KXG2PJ551I - AVELUMAB

Avelumab is a human immunoglobulin G1 (IgG1) monoclonal antibody directed against programmed death ligand 1 (PD-L1). Avelumab binds PD-L1 and blocks the interaction between PD-L1 and the programmed death 1 (PD-1) and B7.1 receptors. This removes the suppressive effects of PD-L1 on cytotoxic CD8+ T-cells, resulting in the restoration of anti-tumour T-cell responses. Read about Avelumab

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
BAVENCIO Concentrate for solution	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
L01FF04	Avelumab	L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01F Monoclonal antibodies and antibody drug conjugates → L01FF PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) inhibitors
Discover more medicines within L01FF04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 11671G, 11679Q, 11685B, 11695M
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 525418100050401
Country: CA	Health Products and Food Branch	Identifier(s): 02469723
Country: EE	Ravimiamet	Identifier(s): 1753275
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 1171214001
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 480316
Country: FR	Base de données publique des médicaments	Identifier(s): 60199966
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 348648
Country: HK	Department of Health Drug Office	Identifier(s): 65956
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 8147
Country: JP	医薬品医療機器総合機構	Identifier(s): 4291438A1022
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1083944
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 148008
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100400386
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W65131001
Country: SG	Health Sciences Authority	Identifier(s): 15672P
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699808770134
Country: US	FDA, National Drug Code	Identifier(s): 44087-3535